Jeremy Warner, MD, MS, FAMIA, FASCO

Rapid Growth in Patient Portal Messages Underscores the Need for Actionable Paths Forward | JCO Clinical Cancer Informatics

Rapid Growth in Patient Portal Messages Underscores the Need for Actionable Paths Forward | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... #JCOCCI

Kids or Adults: Reflections on Choosing a Path in Oncology Dr. Elaine Fan shares considerations and personal reflections on choosing to purse the pediatric or adult oncology track to help guide trainees that are torn between the two.

Kids or Adults: Reflections on Choosing a Path in Oncology | ASCO Connection connection.asco.org/do/kids-adul...

Clinician's Artificial Intelligence Checklist and Evaluation Questionnaire: Tools for Oncologists to Assess Artificial Intelligence and Machine Learning Models | JCO Clinical Cancer Informatics Advancements in oncology are accelerating in the fields of artificial intelligence (AI) and machine learning. The complexity and multidisciplinary nature of oncology necessitate a cautious approach to...

Exciting new article: Clinician's Artificial Intelligence Checklist and Evaluation Questionnaire: Tools for Oncologists to Assess Artificial Intelligence and Machine Learning Models | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI @ascocancer.bsky.social

JCO Journals are now on BlueSky! Give us a follow. @jco-asco.bsky.social @pamelakunzmd.bsky.social @ethicsdoctorp.bsky.social @hemoncwarner.bsky.social @kvanloonmd.bsky.social

America in 2025 or Hollow Knight: Silksong? 1. It’s the hotly anticipated sequel of a late 2010s, grimdark existential nightmare. 2. The economy is really, really bad. Like. Really bad. 3. Th...

America in 2025 or Hollow Knight: Silksong? www.mcsweeneys.net/articles/ame...

Enhancing Readability of Lay Abstracts and Summaries for Urologic Oncology Literature Using Generative Artificial Intelligence: BRIDGE-AI 6 Randomized Controlled Trial | JCO Clinical Cancer Informatic... PURPOSETo evaluate a generative artificial intelligence (GAI) framework for creating readable lay abstracts and summaries (LASs) of urologic oncology research, while maintaining accuracy, completeness...

Enhancing Readability of Lay Abstracts and Summaries for Urologic Oncology Literature Using Generative Artificial Intelligence: BRIDGE-AI 6 Randomized Controlled Trial | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI

Evaluating the Minimal Common Oncology Data Elements Suitability in Enhancing Clinical Observational Research | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... #JCOCCI #mCODE

Review and Commentary on Digital Pathology and Artificial Intelligence in Pathology | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... #JCOCCI

Safe and Responsible Use of Artificial Intelligence in Health Care: Current Regulatory Landscape and Considerations for Regulatory Policy | JCO Clinical Cancer Informatics The integration of artificial intelligence (AI) into health care promises transformative advancements in diagnostics, treatment, and operational efficiency. However, this transformation introduces sig...

Safe and Responsible Use of Artificial Intelligence in Health Care: Current Regulatory Landscape and Considerations for Regulatory Policy | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI

Machine Learning Model Integrating Computed Tomography Image–Derived Radiomics and Circulating miRNAs to Predict Residual Teratoma in Metastatic Nonseminoma Testicular Cancer | JCO Clinical Cancer Inf... PURPOSEChemotherapy is the primary treatment for metastatic nonseminomatous germ cell tumors (mNSGCTs), but patients often encounter postchemotherapy residual disease. Accurate noninvasive methods are...

Machine Learning Model Integrating Computed Tomography Image–Derived Radiomics and Circulating miRNAs to Predict Residual Teratoma in Metastatic Nonseminoma Testicular Cancer | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... #JCOCCI

Building Trust in Health Science Roundtable: Learning & Leading—Together - NAM The National Academy of Medicine’s Building Trust in Health Science Collaborative, supported by the Robert Wood Johnson Foundation, brings together community

nam.edu/event/buildi...

Extraction of Social Determinants of Health From Electronic Health Records Using Natural Language Processing | JCO Clinical Cancer Informatics PURPOSESocial Determinants of Health (SDoH) have a significant effect on health outcomes and inequalities. SDoH can be extracted from electronic health records (EHR) to aid policy development and rese...

Extraction of Social Determinants of Health From Electronic Health Records Using Natural Language Processing | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... #JCOCCI

Analysis of Tumor Microenvironmental Features Between Primary and Synchronous Liver Metastases From Patients With Colorectal Cancers Using a Deep Learning Algorithm | JCO Clinical Cancer Informatics PURPOSEThe development of colorectal liver metastases (CRLMs) is associated with poor prognosis, and recent data suggest that metastasis to the liver is associated with resistance to immunotherapy. We...

Analysis of Tumor Microenvironmental Features Between Primary and Synchronous Liver Metastases From Patients With Colorectal Cancers Using a Deep Learning Algorithm | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI

Deep Learning–Based Body Composition Analysis for Outcome Prediction in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Insights From the LOTIS-2 Trial | JCO Clinical Cancer Informatics PURPOSEThe present study aimed to investigate the role of body composition as an independent image-derived biomarker for clinical outcome prediction in a clinical trial cohort of patients with relapse...

Deep Learning–Based Body Composition Analysis for Outcome Prediction in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Insights From the LOTIS-2 Trial | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI

Consumer Wearable Device Measures of Gait Cadence and Activity Fragmentation as Predictors of Survival Among Patients Undergoing Chemotherapy | JCO Clinical Cancer Informatics PURPOSEConsumer wearable devices provide new opportunities for measuring patterns of objective daily physical activity throughout cancer treatment. In addition to capturing step counts, these devices ...

Consumer Wearable Device Measures of Gait Cadence and Activity Fragmentation as Predictors of Survival Among Patients Undergoing Chemotherapy | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI

Disparities in Patient Portal Messaging Among Oncology Patients Enrolled in the Patient Portal | JCO Clinical Cancer Informatics PURPOSEPrevious studies have consistently reported disparities in electronic health record portal enrollment. Among patients enrolled in a portal, it is less clear whether there are disparities in usa...

Disparities in Patient Portal Messaging Among Oncology Patients Enrolled in the Patient Portal | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI

Reliability of Large Language Model Knowledge Across Brand and Generic Cancer Drug Names | JCO Clinical Cancer Informatics PURPOSETo evaluate the performance and consistency of large language models (LLMs) across brand and generic oncology drug names in various clinical tasks, addressing concerns about potential fluctuati...

Reliability of Large Language Model Knowledge Across Brand and Generic Cancer Drug Names | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI @daniellebitterman.bsky.social

I heard this morning that my informatics colleague Dr. Atul Butte passed after a battle with cancer. He was a giant in the field & inspired many of us over his distinguished career. He was a passionate champion of the power of big data & his impact on our field is immeasurable. RIP Atul & thanks.

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study | Journal of Clinical Oncology ascopubs.org/doi/10.1200/...

Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study PURPOSETumor treating fields (TTFields) use alternating electric fields to disrupt cancer cell proliferation. Feasibility of TTFields therapy with gemcitabine/nab-paclitaxel was previously demonstrate...

Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study | Journal of Clinical Oncology ascopubs.org/doi/10.1200/...

Report: Creating a 5-second AI video is like running a microwave for an hour That's a long time in the microwave.

So…about AI’s energy use…

“…to create a five-second video, a newer AI model uses ‘about 3.4 million joules, more than 700 times the energy required to generate a high-quality image’. That's the equivalent of running a microwave for over an hour.”

Telehealth and Emergency Department Use Among Commercially Insured, Medicaid, and Medicare Patients Receiving Systemic Cancer Therapy in Washington State After COVID-19 | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... @emiliemgunn.bsky.social

ASCO and Google create ‘walled garden’ AI tool for doctors to query group’s guidelines ASCO and Google Cloud's AI tool is meant to help oncologists query just its trusted cancer treatment guidelines, without extraneous information.

Just announced: ASCO and Google Cloud launch the ASCO Guidelines Assistant, an AI tool for fast access to ASCO's trusted and expert-developed clinical cancer guidelines. Read more in @statnews.com

Adding @kenlkehl.bsky.social - congrats on your paper!

Use of Large Language Models in Clinical Cancer Research | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10....

Use of Large Language Models in Clinical Cancer Research | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10....

Frontiers | Summarizing clinical evidence utilizing large language models for cancer treatments: a blinded comparative analysis

Our new article evaluating commercial LLMs head-to-head on summarizing multiple myeloma treatments is now published, check it out! www.frontiersin.org/journals/dig... @smrubinstein.bsky.social @ecquis.bsky.social

We issued a new guideline update on systemic therapy in patients with metastatic castration-resistant prostate cancer. #mCRPC

Read more: brnw.ch/21wSrFa

Honored to be a featured voice for #ASCO25
Will be sharing highlights from a patient/research advocacy perspective & likely focus in digital health interventions, supportive care advances, and diagnostics that lead to treatment optimization & risk mitigation
TY @ascocancer.bsky.social for the oppty

Our new weekly content update is now available: hemonc.org/wiki/Weekly_.... @peteryang.hemonc.org @ecquis.bsky.social